Skip to content
PICO Portalanswers from OpenAlex

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma

PaperCitations, authors & open-access status

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma is a paper indexed in PICO Portal from OpenAlex.

How many citations does Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma have?

PICO Portalcitation count

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma has 484 citations in the OpenAlex counts PICO Portal stores.

When was Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma published?

PICO Portalyear

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma has 2017 year in the PICO Portal index.

What is the open-access status of Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma?

PICO Portaloa status

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma has closed oa status in the PICO Portal index.

What is the DOI of Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma?

PICO Portaldoi

The DOI for Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma is on the source record.

What is the PMID of Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma?

PICO Portalpmid

The PMID for Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma is on the source record.

What is the OpenAlex record for Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma?

PICO Portalopenalex

The OpenAlex for Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial